A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-16-0395
Full Text
Open PDFAbstract
Available in full text
Date
October 4, 2016
Authors
Publisher
American Association for Cancer Research (AACR)